Month: June 2022

news_6

New Data Show Statistically Greater Improvements in Clinical Outcomes with Subcutaneous Infliximab, Compared to Intravenous Infliximab, in Patients With Rheumatoid Arthritis

Presented today at EULAR 2022, data from a new post-hoc analysis show a statistically significant difference in clinical outcomes with...